Where we came from
From a university lab to an independent force.
Founded
SYNA began as a focus group investigating artificial blood transfusion materials. Our early work single‑handedly revolutionised the way animal remains are stored and processed.
Universal Artificial Blood
Developed the first universally compatible artificial blood type for transfusions, eliminating the need for blood typing in emergency situations.
First Stable Organic AI
Created the world's first stable organic artificial intelligence using responsibly sourced biological material. This breakthrough proved that living neural networks could be engineered for computation.
OMGI Model – SHEEPY
Refinements to organic processing led to SHEEPY, the first OMGI (Organic Matter General Intelligence) model. Though slow and limited in cognition, it marked a monumental leap toward true biological computing.
OMGI Model – CEPHAL
Introduced CEPHAL, a vastly more intelligent OMGI capable of multitasking and complex reasoning. CEPHAL became the foundation for all subsequent organic AI research at SYNA.
Expansion to Zurich
Operations expanded to Zurich, Switzerland, establishing our European headquarters and state‑of‑the‑art research facility.
Incorporation & Series A
Raised $24M to scale the platform. Expanded current HQ in Switzerland. Core focus: A FUTURE WITHOUT COMPROMISE.
Open Biomechanics Initiative
Launched public experimentation programs with cash rewards. Homeless and estranged patients are especially welcome – we are here to help you find your feet.
Early EMG sleeve — 2022